805-P — 2012: Improved Glycemic Control and Variability During Insulin Intensification Improve Patient-Centered Outcomes in Type 1 Diabetes
Psychosocial – Behavioral Medicine Presented on Saturday, June 9, 2012 11:30 AM Author(s): MARCIAA. TESTA,.
850-P — 2012: Assessing the Comparative Effectiveness (CE) of Basal-Bolus vs. Premix Insulin Using Continuous Glucose Monitoring (CGM) Summary Measures
Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 10, 2012 12:00.
Impact of Weight Loss on Patient-Reported Outcomes in Obese Type 2 Diabetes
Session: New Findings from Controlled Behavioral Interventions Abstract Number: 1-OR Title: Impact of Weight Loss.
681-P — 2013: Socioeconomic and Demographic Predictors of Internet and Social Media Use in Persons with Diabetes
Diabetes Education Presented on Monday, June 24, 2013 12:00 PM Author(s): MARCIAA. TESTA, DONALD C..
1165-P — 2014 ePoster: Development of a Personalized, Patient-Centered Glycemic Control Benchmarking Tool for T2DM
MARCIA A. TESTA, DONALD C. SIMONSON, Boston, MA Presented on Sunday, June 15, 2014 12:00.
839-P — 2014 CGM and SMBG Analytics Predict Hypoglycemic Risk and Symptoms during Intensive Insulin Titration
Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 15, 2014 12:00.
Load more